\-\ Texto\\:\\ \ \(0\)\
\-\ chem\\ 7\\ reveals\\ no\\ electrolyte\\ abnormalities\\ and\\ normal\\ renal\\ function\\.\ \(0\)\
\-\ for\\ asymptomatic\\ patients\\ with\\ small\\ \\(\\<4cm\\)\\,\\ single\\/few\\ masses\\,\\ no\\ further\\ follow\\-up\\ required\\.\\ \\ for\\ questionable\\ or\\ symptomatic\\ masses\\,\\ follow\\-up\\ with\\ us\\ or\\ tumor\\ resection\\ may\\ be\\ prudent\\.\\ \\ a\\ few\\ patients\\ who\\ present\\ with\\ hemorrhage\\ may\\ be\\ a\\ surgical\\ emergency\\ \\(1\\)\\.\\ \\ if\\ the\\ diagnosis\\ of\\ tuberous\\ sclerosis\\ is\\ considered\\ \\(present\\ at\\ younger\\ age\\,\\ multiple\\/large\\/bilateral\\ tumors\\,\\ symptomatic\\)\\,\\ may\\ need\\ to\\ further\\ screen\\ with\\ skin\\,\\ opthalmologic\\,\\ neurologic\\ examinations\\,\\ and\\ brain\\ mri\\ \\(2\\)\\.\ \(0\)\
\-\ axial\\ ct\\ of\\ the\\ abdomen\\ demonstrates\\ solitary\\ 1cm\\ mass\\ in\\ right\\ kidney\\,\\ with\\ an\\ attenuation\\ of\\ \\-20\\ hounsfield\\ units\\.\ \(0\)\
\-\ angiomyolipoma\ \(35\)\
\-\ renal\\ cell\\ carcinoma\\,\\ teratoma\\,\\ oncocytoma\\,\\ xanthogranulomatous\\ pyelonephritis\\,\\ wilms\\ tumor\\,\\ liposarcoma\\,\\ angiomyolipoma\\.\\ \\(1\\)\ \(0\)\
\-\ 68\\-year\\-old\\ female\\ with\\ a\\ 30\\-pack\\-year\\ smoking\\ history\\,\\ presents\\ with\\ cough\\ and\\ nose\\ bleed\\.\\ \\ cxr\\ reveals\\ a\\ nodular\\ density\\,\\ which\\ further\\ evaluated\\ with\\ chest\\ ct\\.\\ \\ chest\\ ct\\ has\\ incidental\\ finding\\ of\\ possible\\ hepatic\\ vascular\\ malformation\\.\\ \\ abdominal\\ ultrasound\\ is\\ recommended\\ to\\ evaluate\\ liver\\ findings\\.\\ \\ during\\ abdominal\\ ultrasound\\,\\ four\\ echogenic\\ masses\\ are\\ noted\\ in\\ the\\ right\\ kidney\\.\\ \\ further\\ evaluation\\ of\\ renal\\ masses\\ with\\ abdominal\\ ct\\ is\\ then\\ recommended\\.\ \(0\)\
\-\ benign\\ tumors\\.\\ \\ majority\\ are\\ small\\ and\\ single\\.\\ \\ composed\\ of\\ fat\\,\\ vascular\\ and\\ smooth\\ muscle\\ tissues\\.\\ \\ majority\\ of\\ cases\\ are\\ asymptomatic\\,\\ but\\ may\\ present\\ with\\ flank\\ pain\\,\\ palpable\\ mass\\,\\ hematuria\\,\\ altered\\ renal\\ function\\,\\ or\\ spontaneous\\ hemorrhage\\.\\ \\ incidence\\ in\\ the\\ us\\ between\\ 0\\.3\\-3\\%\\.\\ \\ more\\ common\\ in\\ females\\ \\(4\\:1\\)\\.\\ \\ 80\\%\\ of\\ cases\\ involve\\ the\\ right\\ kidney\\.\\ \\ associated\\ with\\ tuberous\\ sclerosis\\ in\\ 20\\%\\ of\\ cases\\ \\(lesions\\ are\\ usually\\ multiple\\,\\ larger\\,\\ and\\ bilateral\\)\\.\\ \\ 80\\%\\ of\\ patients\\ with\\ tuberous\\ sclerosis\\ have\\ angiomyolipomas\\.\\ \\(2\\)\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ tuberous\\:\\ 0\\.04383209217198621\ \(0\)\
\-\ masses\\:\\ 0\\.03588313537883338\ \(0\)\
\-\ further\\:\\ 0\\.03375707008447525\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.031999731539359325\ \(0\)\
\-\ renal\\:\\ 0\\.03189410620444806\ \(0\)\
\-\ sclerosis\\:\\ 0\\.02859610465925166\ \(0\)\
\-\ kidney\\:\\ 0\\.028047050823447297\ \(0\)\
\-\ single\\/few\\:\\ 0\\.027377386409833844\ \(0\)\
\-\ multiple\\/large\\/bilateral\\:\\ 0\\.027377386409833844\ \(0\)\
\-\ 68\\-year\\-old\\:\\ 0\\.027377386409833844\ \(0\)\
\-\ 30\\-pack\\-year\\:\\ 0\\.027377386409833844\ \(0\)\
\-\ 0\\.3\\-3\\:\\ 0\\.027377386409833844\ \(0\)\
\-\ cases\\:\\ 0\\.026523082583675146\ \(0\)\
\-\ majority\\:\\ 0\\.026089427994566698\ \(0\)\
\-\ \\-20\\:\\ 0\\.025224755414306063\ \(0\)\
\-\ 80\\:\\ 0\\.024967253902917742\ \(0\)\
\-\ \\%\\:\\ 0\\.024761751967031148\ \(0\)\
\-\ opthalmologic\\:\\ 0\\.02396554700403226\ \(0\)\
\-\ 4\\:1\\:\\ 0\\.02396554700403226\ \(0\)\
\-\ may\\:\\ 0\\.02328358222233694\ \(0\)\
\-\ \\,\\:\\ 0\\.022699291207971303\ \(0\)\
\-\ function\\:\\ 0\\.022500382441467626\ \(0\)\
\-\ us\\:\\ 0\\.02226341495100566\ \(0\)\
\-\ recommended\\:\\ 0\\.022003222766476715\ \(0\)\
\-\ prudent\\:\\ 0\\.02181291600850448\ \(0\)\
\-\ symptomatic\\:\\ 0\\.021086853569529267\ \(0\)\
\-\ reveals\\:\\ 0\\.020765513976987723\ \(0\)\
\-\ patients\\:\\ 0\\.020604732292230057\ \(0\)\
\-\ xanthogranulomatous\\:\\ 0\\.020226501027864757\ \(0\)\
\-\ tumors\\:\\ 0\\.01993612644515839\ \(0\)\
\-\ electrolyte\\:\\ 0\\.01993050668064636\ \(0\)\
\-\ abdominal\\:\\ 0\\.019899868678156355\ \(0\)\
\-\ angiomyolipomas\\:\\ 0\\.018967292617590954\ \(0\)\
\-\ hounsfield\\:\\ 0\\.018073870032336976\ \(0\)\
\-\ present\\:\\ 0\\.017981448017997028\ \(0\)\
\-\ \\(\\:\\ 0\\.01794687518618287\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.01794156768941669\ \(0\)\
\-\ \\)\\:\\ 0\\.01772764452455416\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.017666189963826306\ \(0\)\
\-\ chem\\:\\ 0\\.017639826733035244\ \(0\)\
\-\ vascular\\:\\ 0\\.0174025047697124\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.01726731050584933\ \(0\)\
\-\ oncocytoma\\:\\ 0\\.017259074179953465\ \(0\)\
\-\ 4cm\\:\\ 0\\.017141868192429095\ \(0\)\
\-\ 1cm\\:\\ 0\\.016518667274844773\ \(0\)\
\-\ wilms\\:\\ 0\\.016425956209162536\ \(0\)\
\-\ examinations\\:\\ 0\\.016335932802723864\ \(0\)\
\-\ units\\:\\ 0\\.016335932802723864\ \(0\)\
\-\ composed\\:\\ 0\\.01624844560717512\ \(0\)\
\-\ liposarcoma\\:\\ 0\\.015999865769679662\ \(0\)\
\-\ ultrasound\\:\\ 0\\.01574610301246151\ \(0\)\
\-\ younger\\:\\ 0\\.015487195737507462\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.015487195737507462\ \(0\)\
\-\ screen\\:\\ 0\\.015420406280299502\ \(0\)\
\-\ nose\\:\\ 0\\.015290987968496494\ \(0\)\
\-\ bleed\\:\\ 0\\.015166747798888732\ \(0\)\
\-\ altered\\:\\ 0\\.015047287299423529\ \(0\)\
\-\ questionable\\:\\ 0\\.014989237196901315\ \(0\)\
\-\ ct\\:\\ 0\\.01484849258872103\ \(0\)\
\-\ females\\:\\ 0\\.014767314948509561\ \(0\)\
\-\ are\\:\\ 0\\.01447048288856648\ \(0\)\
\-\ smoking\\:\\ 0\\.013402822216261594\ \(0\)\
\-\ need\\:\\ 0\\.013234911591198625\ \(0\)\
\-\ echogenic\\:\\ 0\\.01320239202639336\ \(0\)\
\-\ solitary\\:\\ 0\\.013170209457959985\ \(0\)\
\-\ larger\\:\\ 0\\.012779621298677272\ \(0\)\
\-\ chest\\:\\ 0\\.01270018012458086\ \(0\)\
\-\ 1\\:\\ 0\\.012629356322731098\ \(0\)\
\-\ hematuria\\:\\ 0\\.01258802636387808\ \(0\)\
\-\ involve\\:\\ 0\\.012509399631007615\ \(0\)\
\-\ flank\\:\\ 0\\.012483626951458871\ \(0\)\
\-\ teratoma\\:\\ 0\\.012407567883110128\ \(0\)\
\-\ spontaneous\\:\\ 0\\.01238262325050993\ \(0\)\
\-\ tumor\\:\\ 0\\.012374113674601311\ \(0\)\
\-\ small\\:\\ 0\\.012227175679385829\ \(0\)\
\-\ evaluated\\:\\ 0\\.01216670380129064\ \(0\)\
\-\ incidence\\:\\ 0\\.01216670380129064\ \(0\)\
\-\ few\\:\\ 0\\.011943183616119558\ \(0\)\
\-\ smooth\\:\\ 0\\.011615977045753637\ \(0\)\
\-\ four\\:\\ 0\\.01152041288840347\ \(0\)\
\-\ 2\\:\\ 0\\.011429220475220783\ \(0\)\
\-\ cxr\\:\\ 0\\.011198857984860488\ \(0\)\
\-\ nodular\\:\\ 0\\.01113170747550283\ \(0\)\
\-\ neurologic\\:\\ 0\\.011082280595670844\ \(0\)\
\-\ hepatic\\:\\ 0\\.011082280595670844\ \(0\)\
\-\ tissues\\:\\ 0\\.010892083001755568\ \(0\)\
\-\ single\\:\\ 0\\.010756708976678358\ \(0\)\
\-\ evaluate\\:\\ 0\\.010727410739928797\ \(0\)\
\-\ considered\\:\\ 0\\.010712864624051696\ \(0\)\
\-\ attenuation\\:\\ 0\\.010669630653497013\ \(0\)\
\-\ malformation\\:\\ 0\\.010584927492255836\ \(0\)\
\-\ \\<\\:\\ 0\\.010242439526403075\ \(0\)\
\-\ skin\\:\\ 0\\.010192947003847756\ \(0\)\
\-\ 7\\:\\ 0\\.010168493412447428\ \(0\)\
\-\ cough\\:\\ 0\\.010168493412447428\ \(0\)\
\-\ emergency\\:\\ 0\\.010049032912982222\ \(0\)\
\-\ incidental\\:\\ 0\\.010049032912982222\ \(0\)\
\-\ abnormalities\\:\\ 0\\.009747716216454087\ \(0\)\
\-\ required\\:\\ 0\\.00955194258319026\ \(0\)\
\-\ 20\\:\\ 0\\.009541972783096321\ \(0\)\
\-\ muscle\\:\\ 0\\.00953203488641722\ \(0\)\
\-\ then\\:\\ 0\\.009443996516838787\ \(0\)\
\-\ palpable\\:\\ 0\\.00940565541180059\ \(0\)\
\-\ or\\:\\ 0\\.009330957288481748\ \(0\)\
\-\ benign\\:\\ 0\\.00915854151252547\ \(0\)\
\-\ liver\\:\\ 0\\.009149756244822123\ \(0\)\
\-\ possible\\:\\ 0\\.008937832977900843\ \(0\)\
\-\ density\\:\\ 0\\.008731774400186208\ \(0\)\
\-\ finding\\:\\ 0\\.008552986040492178\ \(0\)\
\-\ between\\:\\ 0\\.008411476820572186\ \(0\)\
\-\ right\\:\\ 0\\.008400295426494566\ \(0\)\
\-\ resection\\:\\ 0\\.008276135576149746\ \(0\)\
\-\ be\\:\\ 0\\.008184824368595833\ \(0\)\
\-\ during\\:\\ 0\\.008121146738893813\ \(0\)\
\-\ age\\:\\ 0\\.008077361259454368\ \(0\)\
\-\ fat\\:\\ 0\\.008071156282241096\ \(0\)\
\-\ usually\\:\\ 0\\.008058783397101735\ \(0\)\
\-\ brain\\:\\ 0\\.0079855637369651\ \(0\)\
\-\ abdomen\\:\\ 0\\.00786144181023508\ \(0\)\
\-\ evaluation\\:\\ 0\\.007708816136108098\ \(0\)\
\-\ axial\\:\\ 0\\.007573886571639352\ \(0\)\
\-\ carcinoma\\:\\ 0\\.007521514503154864\ \(0\)\
\-\ mass\\:\\ 0\\.007381745384767481\ \(0\)\
\-\ if\\:\\ 0\\.007201066564536135\ \(0\)\
\-\ cell\\:\\ 0\\.007168449414849336\ \(0\)\
\-\ lesions\\:\\ 0\\.007104225174981204\ \(0\)\
\-\ common\\:\\ 0\\.006944929229678251\ \(0\)\
\-\ who\\:\\ 0\\.006919156550129509\ \(0\)\
\-\ more\\:\\ 0\\.00663719350718064\ \(0\)\
\-\ in\\:\\ 0\\.0065434352506250765\ \(0\)\
\-\ bilateral\\:\\ 0\\.006440427730790199\ \(0\)\
\-\ noted\\:\\ 0\\.006290127914449048\ \(0\)\
\-\ associated\\:\\ 0\\.006262306092881061\ \(0\)\
\-\ mri\\:\\ 0\\.006097129984206894\ \(0\)\
\-\ diagnosis\\:\\ 0\\.006093848853355341\ \(0\)\
\-\ demonstrates\\:\\ 0\\.005796960253581323\ \(0\)\
\-\ have\\:\\ 0\\.005746702106723887\ \(0\)\
\-\ but\\:\\ 0\\.005659948139855707\ \(0\)\
\-\ findings\\:\\ 0\\.005648561912391179\ \(0\)\
\-\ multiple\\:\\ 0\\.005589459638134375\ \(0\)\
\-\ surgical\\:\\ 0\\.005578328479041781\ \(0\)\
\-\ female\\:\\ 0\\.005455777240521222\ \(0\)\
\-\ presents\\:\\ 0\\.005421255576111571\ \(0\)\
\-\ no\\:\\ 0\\.005344373606855912\ \(0\)\
\-\ is\\:\\ 0\\.005238733960106139\ \(0\)\
\-\ has\\:\\ 0\\.00498354028103813\ \(0\)\
\-\ which\\:\\ 0\\.00495386517777189\ \(0\)\
\-\ a\\:\\ 0\\.004926705612653431\ \(0\)\
\-\ for\\:\\ 0\\.0045286220412591\ \(0\)\
\-\ with\\:\\ 0\\.00436040407788409\ \(0\)\
\-\ normal\\:\\ 0\\.004160287126084164\ \(0\)\
\-\ an\\:\\ 0\\.003669766659269347\ \(0\)\
\-\ history\\:\\ 0\\.0036652625394629915\ \(0\)\
\-\ of\\:\\ 0\\.003618130459564858\ \(0\)\
\-\ at\\:\\ 0\\.0035955377417131455\ \(0\)\
\-\ and\\:\\ 0\\.0033542050757556234\ \(0\)\
\-\ pain\\:\\ 0\\.003241019153822157\ \(0\)\
\-\ to\\:\\ 0\\.002652596946850846\ \(0\)\
\-\ \\.\\:\\ 0\\.0024254341432969504\ \(0\)\
\-\ the\\:\\ 0\\.0021467280233482267\ \(0\)\
